LLLili Liu

Lili Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lili Liu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Huimin Li

    Jiangxi Engineering Laboratory of Zebrafish Modeling and Drug Screening for Human Diseases, Key Laboratory of Jiangxi Province for Biological Invasion and Biosecurity, Jiangxi Key Laboratory of Developmental Biology of Organs and Epigenetics, College of Life Sciences, Clinical Research Center of Jinggangshan University, Jinggangshan University, Ji'an 343009, China

    1 shared publication
  • Jianhua Liu

    School of Energy and Power Engineering, University of Shanghai for Science and Technology, Shanghai, China

    1 shared publication
  • Jinfeng Liu

    Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

    1 shared publication
  • Jingjing Yuan

    Department of Otorhinolaryngology—Head and Neck Surgery, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China

    1 shared publication
  • Lili Kong

    Binzhou Med Coll, Yantai Affiliated Hosp, Dept Endocrinol, 717 Jinbu St, Yantai 264100, Peoples R China

    1 shared publication
  • Liwei Fu

    Univ. Stuttgart (Germany)

    1 shared publication

Latest Publications

  • HIV-Related Pulmonary Infection

    by Lili Kong, Lili Liu, Huimin Li, Yibo Lu, Meiji Ren, Zhao Liu, Liwei Fu, Xuhua Yang, Yupeng Liu

  • Open Access

    Yiqi Jiemin decoction alleviates allergic rhinitis in a guinea pig model by suppressing inflammation, restoring Th1/Th2 balance, and improving cellular metabolism

    by Zhanfeng Yan, Lili Liu, Jingjing Yuan, Lulu Jiao, Mo Zhou, Jinfeng Liu, Xiaohui Wen, Siming Liu, Pengpeng Hao, Jianhua Liu, et al.

    We investigated the mechanisms underlying the therapeutic effects of Yiqi Jiemin decoction (YJD), a traditional Chinese medicine (TCM), in the ovalbumin (OVA)-induced allergic rhinitis (AR) model in guinea pigs. YJD significantly decreased infiltration of mast cells and eosinophils into the nasal mucosa of AR model guinea pigs. YJD also increased expression of TGF-β in the nasal mucosa, restored the balance of Th1/Th2 immune cell responses, and decreased serum levels of various pro-inflammatory mediators, including histamine (HA), neuropeptide Y (NPY), acetylcholine (ACH), norepinephrine and immunoglobulin E (IgE). Metabolic analyses using liquid chromatography coupled with high-resolution mass spectrometry revealed that YJD improved cellular metabolism in AR model guinea pigs and increased serum levels of glycocholic acid while decreasing levels 1-palmitoyl lysophosphatidic acid. RNA-sequencing analysis identified BPIFB2 as a potential diagnostic biomarker and therapeutic target for AR. Functional enrichment analyses showed that YJD significantly inhibited cytokine secretion pathways in AR model guinea pigs. These findings demonstrate that YJD protects against OVA-induced AR in guinea pigs by suppressing inflammation in the nasal mucosa, restoring Th1/Th2 balance, and improving cellular metabolism.